Papers Presented at an International Symposium, Held in 1984 at Kollekolle, Denmark

Since the APA's last report on tardive dyskinesia in 1979, considerable research has been conducted on the prevalence, incidence, and risk factors associated with the development of late-occurring neuroleptic side effects. This book summarizes the progress made over the last decade in understanding the differential diagnosis and epidemiology of tardive dyskinesia, as well as risk factors, course, and treatment. The reader will benefit from the book's coverage of * indications for neuroleptic use* alternative maintenance strategies* factors to consider in making a differential diagnosis* frequently encountered problems in dealing with special populations such as children and mentally retarded people* clinical-legal issues related to tardive dyskinesia * clearly specified recommendations for prevention and management

The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.

A very readable and well illustrated 1999 clinical guide to the common side effects of antipsychotic medication.

This book provides a comprehensive yet concise review of geriatric psychiatry in preparation for the board exam, or for reference during practice. Written by experts in the field, this text thoroughly reviews over 500 developmental, biological, diagnostic, and treatment questions for board certification. Unlike any other text on the market, this book takes a broader approach to the subject, making it accessible for physicians as well as other clinicians, including nurses, therapists, and social workers. Absolute Geriatric Psychiatry Review is an excellent resource for all clinicians who will care for the mental health of aging patients, including psychiatrists, neurologists, psychologists, therapists, nurses, social workers, nursing home administrators, and all others.

While Kathleen A. Shea is best known for starting the first national nonprofit organization for tardive dyskinesia, TD is only part of her story. Be ready to be shocked by Kathleen's account of her cataclysmic attempt at Seroquel(R) withdrawal and how it altered her life forever. From the physician who told her to taper off her 14-year experience with Seroquel (quetiapine) in less than 14 days, to the holistic drug withdrawal clinic where she spent almost three months and left much worse than when she arrived, no one seemed to realize they were tapering her at too rapid a pace for her brain chemistry to maintain equilibrium. Though she was on Seroquel for insomnia, and rebound insomnia is the most well-known effect of Seroquel withdrawal, what Kathleen experienced was beyond the wildest imagination of any Seroquel patient and most psychiatric physicians.

"This book has been divided into three main sections. Part I deals with global issues that bear on the assessment and formulation of possible adverse effects and with pertinent concepts related to basic pharmacology, physiology, and medical monitoring. The chapters in Part II present information organized by individual organ systems or specific medical circumstances rather than by drugs or drug classes. This approach seems to provide a logical and comprehensible format that allow readers to search out information as referenced by a particular side effect (and its varied potential causes) and to locate a discussion of practical management strategies. Part III focuses on summary recommendations covering all the material presented in the book and is followed by helpful appendixes on self-assessment questions and resources for practitioners. The book is meant to serve as a ready reference that simultaneously provides scientific and scholarly discussion of available treatment options and presents their scientific rationales."--page xx.